GRM6 Gene

Migration, Crosslink

📖

GRM6 Gene

active

wiki page Created: 2026-04-02T07:19:24 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-grm6

📖 Wiki Page

gene1395 wordssynced 2026-04-02

GRM6 Gene

Introduction

Grm6 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@nicoletti2021]

Overview

This page provides comprehensive information about this gene. See the content below for detailed information. [@luscher2020]

title: GRM6 Gene [@simonyi2020]
description: GRM6 encodes metabotropic glutamate receptor 6 (mGluR6), expressed primarily in retinal ON-bipolar cells where it mediates synaptic transmission in the visual pathway. [@stocchi2023]
tags: gene, glutamate receptor, GPCR, synaptic signaling [@wang2022]
--- [@wu2021]

...

GRM6 Gene

Introduction

Grm6 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@nicoletti2021]

Overview

Mermaid diagram (expand to render)

This page provides comprehensive information about this gene. See the content below for detailed information. [@luscher2020]

title: GRM6 Gene [@simonyi2020]
description: GRM6 encodes metabotropic glutamate receptor 6 (mGluR6), expressed primarily in retinal ON-bipolar cells where it mediates synaptic transmission in the visual pathway. [@stocchi2023]
tags: gene, glutamate receptor, GPCR, synaptic signaling [@wang2022]
--- [@wu2021]

<div class="infobox-header">GRM6 Gene</div>

<div class="infobox-row">
<div class="infobox-label">Symbol</div>
<div class="infobox-value">GRM6</div>
</div>

<div class="infobox-row">
<div class="infobox-label">Full Name</div>
<div class="infobox-value">Glutamate Metabotropic Receptor 6</div>
</div>

<div class="infobox-row">
<div class="infobox-label">Chromosome</div>
<div class="infobox-value">5</div>
</div>

<div class="infobox-row">
<div class="infobox-label">Location</div>
<div class="infobox-value">5q35.3</div>
</div>

<div class="infobox-row">
<div class="infobox-label">NCBI Gene</div>
<div class="infobox-value"><a href="https://www.ncbi.nlm.nih.gov/gene/2917" target="_blank">GRM6</a></div>
</div>

<div class="infobox-row">
<div class="infobox-label">OMIM</div>
<div class="infobox-value"><a href="604096" target="_blank">604096</a></div>
</div>

<div class="infobox-row">
<div class="infobox-label">Ensembl ID</div>
<div class="infobox-value">ENSG00000113282</div>
</div>

<div class="infobox-row">
<div class="infobox-label">UniProt</div>
<div class="infobox-value"><a href="https://www.uniprot.org/uniprot/O43507" target="_blank">O43507</a></div>
</div>

<div class="infobox-row">
<div class="infobox-label">Encoded Protein</div>
<div class="infobox-value">[mGluR6](/proteins/mGluR6)</div>
</div>

<div class="infobox-row">
<div class="infobox-label">Associated Diseases</div>
<div class="infobox-value">Congenital stationary night blindness</div>
</div>

</div>

Function

The GRM6 gene encodes mGluR6 (Glutamate Metabotropic Receptor 6), a member of the metabotropic glutamate receptor family. These receptors are class C G-protein coupled receptors (GPCRs) that play crucial roles in modulating synaptic transmission and neuronal excitability throughout the central nervous system.

Signal Transduction

Metabotropic glutamate receptors (mGluRs) are divided into three groups based on their pharmacology and G-protein coupling:

Group I (GRM1, GRM5): Coupled to Gq proteins, activate phospholipase C (PLC) signaling cascade
Group II (GRM2, GRM3): Coupled to Gi/o proteins, inhibit adenylate cyclase
Group III (GRM4, GRM6, GRM7, GRM8): Coupled to Gi/o proteins, inhibit adenylate cyclase

Expression Pattern

The GRM6 gene shows characteristic expression patterns in the brain, with highest levels in regions relevant to congenital stationary night blindness. This regional specificity underlies its functional roles in specific neural circuits.

Disease Associations

Neurodegenerative Diseases

mGluR6 has been implicated in several neurodegenerative and neuropsychiatric disorders:

[Alzheimer's Disease](/diseases/alzheimers-disease): Dysregulation of mGluR signaling contributes to synaptic dysfunction and excitotoxicity

[Parkinson's Disease](/diseases/parkinsons-disease): Modulation of basal ganglia circuitry through glutamatergic signaling

Schizophrenia: Altered glutamatergic neurotransmission is a key feature

Therapeutic Targeting

mGluR6 is a promising drug target for:

Positive allosteric modulators (PAMs) for cognitive enhancement
Negative allosteric modulators (NAMs) for anxiety and addiction
Subtype-selective compounds for reduced side effects

Key Publications

Conn PJ, et al. "Metabotropic glutamate receptors: physiology, pharmacology, and disease." Annu Rev Pharmacol Toxicol. 2022. [DOI: 10.1146/annurev-pharmtox-052120-013257](https://doi.org/10.1146/annurev-pharmtox-052120-013257)

Niswender CM, Conn PJ. "Metabotropic glutamate receptors: therapeutic targets for Alzheimer's disease." Neuropharmacology. 2023. [DOI: 10.1016/j.neuropharm.2022.109256](https://doi.org/10.1016/j.neuropharm.2022.109256)

Lu Y, et al. "Group I metabotropic glutamate receptors in Parkinson's disease: pathophysiology and therapeutic potential." Acta Neuropathol Commun. 2021. [DOI: 10.1186/s40478-021-01247-x](https://doi.org/10.1186/s40478-021-01247-x)

Allen Brain Atlas Data

Gene Expression

GRM6 (mGluR6) shows highest expression in the retina and specific brain regions:

Retina - Very high expression in photoreceptor cells and bipolar neurons (primary site)
Cerebellum - Low to moderate expression in Purkinje cells
Brainstem - Moderate expression in superior colliculus
Hippocampus - Very low expression

Single-Cell Expression

Single-cell RNA sequencing data from the Allen Brain Atlas shows GRM6 expression primarily in:

Retinal neurons: Photoreceptors, bipolar cells, ganglion cells
Some brain neurons: Low expression in specific brainstem nuclei

Brain Region Expression Levels

| Region | Expression Level | Data Source |
|--------|-----------------|-------------|
| Retina | Very High | Human Retina |
| Cerebellum | Low-Medium | Mouse Brain |
| Brainstem | Medium | Mouse Brain |
| Hippocampus | Very Low | Mouse Brain |

External Resources

[Human Brain Map - GRM6 Expression](https://human.brain-map.org/microarray/search/show?search_term=GRM6)
[Allen Cell Type Atlas](https://celltypes.brain-map.org/)
[BrainSpan Transcriptome Atlas](https://brainspan.org/)

External Links

[PubMed - Research Papers](https://pubmed.ncbi.nlm.nih.gov/)
[Allen Brain Atlas](https://brain-map.org/)
[BrainSpan Atlas](https://brainspan.org/)

Molecular Mechanisms

Retinal Signal Transduction

mGluR6 mediates ON-bipolar cell signaling in the retina:

G-protein cascade: Gi/o coupling activates Go protein
cGMP pathway: Reduces cGMP levels in photoreceptor terminals
Channel closure: Closure of TRPM1 channels causes depolarization
ON response: Generates the ON response in visual processing

Receptor Pharmacology

mGluR6 has distinct pharmacological properties:

Agonists: L-AP4 (Group III agonist), LY341495
Antagonists: CPPG, MSOP (Group III antagonists)
PAMs: Monoacylglycerols (endogenous PAMs)
Specificity: Highest subtype selectivity among mGluRs

Post-translational Modifications

Key regulatory modifications:

| Modification | Site | Function |
|--------------|------|----------|
| Phosphorylation | Ser/Thr residues | Desensitization |
| Glycosylation | N-linked glycans | Surface expression |
| Disulfide bonds | Cys domains | Structural stability |

Role in Visual System

ON-Bipolar Cell Function

mGluR6 is essential for ON-bipolar cell transmission:

Glutamate detection: Postsynaptic glutamate response
Signal integration: Converts light signals to neural signals
Contrast detection: Essential for light/dark boundary detection
Visual acuity: Critical for high-resolution vision

Congenital Stationary Night Blindness (CSNB)

GRM6 mutations cause CSNB:

Inheritance: Autosomal recessive
Phenotype: Night blindness, reduced visual acuity
Mechanism: Loss of ON-bipolar cell function
Treatment: Supportive care, low vision aids

Therapeutic Implications

Visual Restoration

mGluR6-targeted approaches for visual disorders:

Gene therapy: AAV-GRM6 delivery to retina
Small molecules: PAMs to enhance function
Optogenetic approaches: Alternative pathways

CNS Applications

Despite retinal specificity, mGluR6 has CNS relevance:

Brain expression: Low levels in specific regions
Circuit modulation: May affect non-visual pathways
Research tool: Model for GPCR function

Structural Biology

Protein Domains

mGluR6 shares the canonical Class C GPCR architecture:

VFTD: Large extracellular ligand-binding domain
CRD: Cysteine-rich domain linking extracellular and transmembrane
7TM: Seven transmembrane helices
C-terminal tail: Intracellular regulatory domain

Structural Features

Unique features of mGluR6:

Highest ligand affinity: Among Group III mGluRs
Slow deactivation: Prolonged signal duration
Dimer interface: Essential for function

Research Models

Animal Models

| Model | Application | Phenotype |
|-------|-------------|-----------|
| Grm6 KO mice | Loss-of-function | CSNB-like phenotype |
| Grm6 mutants | Modeling CSNB | Visual deficits |
| Transgenic | Overexpression | Enhanced ON response |

In Vitro Systems

HEK293 cells: Recombinant expression
Retinal explants: Organotypic cultures
iPSC-derived: Retinal bipolar cells

Clinical Considerations

Diagnosis

CSNB diagnosis involves:

ERG testing: Absent or reduced b-wave
Genetic testing: GRM6 mutation analysis
Fundus exam: Usually normal appearance

Management

Current management strategies:

Low vision aids: Magnification, lighting
Genetic counseling: Family planning
Research participation: Clinical trials

Future Directions

Research Priorities

Gene therapy: AAV delivery optimization

PAM development: Brain-penetrant compounds
Biomarkers: Treatment response markers
iPSC models: Patient-specific studies

Background

The study of Grm6 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Cross-References

Metabotropic Glutamate Receptors
Glutamate Signaling
Synaptic Plasticity
Excitotoxicity

Recent Research

Recent PubMed-indexed publications (2024-present):

[System biology analysis reveals that Grm6 is associated with glutamate signaling](https://pubmed.ncbi.nlm.nih.gov/41867370/). Mol Vis. 2025.

[Novel Grm6 Variant in a no b-wave (nob) Mouse Model: Phenotype Characterization](https://pubmed.ncbi.nlm.nih.gov/40923695/). Invest Ophthalmol Vis Sci. 2025 Sep.

References

[Conn PJ, et al, "Metabotropic glutamate receptors: physiology, pharmacology, and disease." Annu Rev Pharmacol Toxicol (2022)](https://doi.org/10.1146/annurev-pharmtox-010919-023318)

[Nicoletti F, et al, "Metabotropic glutamate receptors: from signaling to pathology." Prog Neurobiol (2021)](https://doi.org/10.1016/j.pneurobio.2021.102021)

[Luscher C, Huber KM, "Group 1 metabotropic glutamate receptor-dependent long-term potentiation." Neuropharmacology (2020)](https://doi.org/10.1016/j.neuropharm.2019.107730)

[Simonyi A, et al, "Group I metabotropic glutamate receptors in neurodegeneration and neuroinflammation." Neuropharmacology (2020)](https://doi.org/10.1016/j.neuropharm.2020.108023)

[Stocchi F, et al, "Metabotropic glutamate receptors and Parkinson's disease: opportunities for therapeutic intervention." CNS Drugs (2023)](https://doi.org/10.1007/s40263-023-01005-8)

[Wang H, et al, "Targeting metabotropic glutamate receptors for neuroprotective therapy in Parkinson's disease." Prog Neuropsychopharmacol Biol Psychiatry (2022)](https://doi.org/10.1016/j.pnpbp.2022.110687)

[Wu J, et al, "Metabotropic glutamate receptor modulation and neuroprotection: challenges and opportunities." Expert Opin Ther Targets (2021)](https://doi.org/10.1080/14728222.2021.1951228)

[Duvoisin et al., mGluR6 in retinal ON bipolar cells (2010)](https://pubmed.ncbi.nlm.nih.gov/20847123/)

[Tsvetkov et al., mGluR6 structure and function (2019)](https://pubmed.ncbi.nlm.nih.gov/31165234/)

[Peachey et al., mGluR6 and congenital stationary night blindness (2012)](https://pubmed.ncbi.nlm.nih.gov/22534638/)

[Zeitz et al., Molecular genetics of CSNB (2015)](https://pubmed.ncbi.nlm.nih.gov/25852713/)

[Martinez et al., mGluR6 gene therapy for retinal degeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29654124/)

[Yang et al., Retinal mGluR6 signaling in visual processing (2019)](https://pubmed.ncbi.nlm.nih.gov/31478912/)

[Koike et al., TRPM1 channels in ON bipolar cells (2010)](https://pubmed.ncbi.nlm.nih.gov/20847120/)

[Morgans et al., mGluR6 signaling cascade (2011)](https://pubmed.ncbi.nlm.nih.gov/21816908/)

📖 View canonical wiki page →

Related Entities

GRM6

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-grm6
kg_node_id	GRM6
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-3791934bca85
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-grm6'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

35%

Debates

0

Incoming

7

Outgoing

7

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

GRM6 Gene

GRM6 Gene

Introduction

Overview

GRM6 Gene

Introduction

Overview

Function

Signal Transduction

Expression Pattern

Disease Associations

Neurodegenerative Diseases

Therapeutic Targeting

Key Publications

Allen Brain Atlas Data

Gene Expression

Single-Cell Expression

Brain Region Expression Levels

External Resources

External Links

Molecular Mechanisms

Retinal Signal Transduction

Receptor Pharmacology

Post-translational Modifications

Role in Visual System

ON-Bipolar Cell Function

Congenital Stationary Night Blindness (CSNB)

Therapeutic Implications

Visual Restoration

CNS Applications

Structural Biology

Protein Domains

Structural Features

Research Models

Animal Models

In Vitro Systems

Clinical Considerations

Diagnosis

Management

Future Directions

Research Priorities

See Also

Background

Cross-References

Recent Research

References

💬 Discussion